LIVANOVA PLC's ticker is LIVN and the CUSIP is G5509L101. A total of 222 filers reported holding LIVANOVA PLC in Q2 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $16,654,000 | -45.2% | 328,030 | -32.6% | 2.08% | -31.8% |
Q2 2022 | $30,395,000 | -26.1% | 486,550 | -3.1% | 3.05% | +11.4% |
Q1 2022 | $41,107,000 | +9.2% | 502,350 | +16.7% | 2.74% | +33.8% |
Q4 2021 | $37,647,000 | -27.1% | 430,600 | -34.0% | 2.05% | -8.0% |
Q3 2021 | $51,644,000 | +391.2% | 652,150 | +421.7% | 2.23% | +430.5% |
Q2 2021 | $10,514,000 | -74.2% | 125,000 | -79.7% | 0.42% | -73.3% |
Q4 2020 | $40,787,000 | -41.4% | 616,030 | -57.4% | 1.57% | -46.0% |
Q2 2020 | $69,572,000 | +25.4% | 1,445,500 | +17.9% | 2.92% | +22.9% |
Q1 2020 | $55,472,000 | -60.0% | 1,225,890 | -19.2% | 2.37% | -45.4% |
Q4 2018 | $138,831,000 | +61.1% | 1,517,780 | +118.4% | 4.34% | +51.9% |
Q3 2018 | $86,173,000 | +7.9% | 695,110 | -13.1% | 2.86% | +12.7% |
Q2 2018 | $79,856,000 | -16.1% | 800,000 | -25.6% | 2.54% | -21.6% |
Q1 2018 | $95,138,000 | +91.1% | 1,075,000 | +72.6% | 3.24% | +99.8% |
Q4 2017 | $49,790,000 | -23.7% | 622,997 | -33.1% | 1.62% | -25.9% |
Q3 2017 | $65,263,000 | +166.6% | 931,530 | +132.9% | 2.19% | +147.4% |
Q2 2017 | $24,484,000 | – | 400,000 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hawk Ridge Capital Management | 1,067,655 | $93,345,000 | 5.74% |
Paradice Investment Management LLC | 1,220,336 | $106,694,000 | 4.67% |
P2 Capital Partners, LLC | 651,583 | $56,968,000 | 4.44% |
Redmile Group, LLC | 2,057,178 | $179,859,000 | 4.09% |
Sachem Head Capital | 1,734,500 | $151,647,000 | 3.57% |
HealthCor Management, L.P. | 430,600 | $37,647,000 | 2.05% |
Greenlight Capital | 341,000 | $29,814,000 | 1.70% |
PURA VIDA INVESTMENTS, LLC | 504,767 | $44,132,000 | 1.60% |
EMINENCE CAPITAL, LP | 1,825,677 | $159,619,000 | 1.52% |
Perpetual Investment Management Ltd | 94,097 | $8,226,000 | 0.94% |